Explore real-world KLOW Blend (KPV/GHK-Cu/TB-500/BPC-157) dosage trends, reconstitution volumes, and vial size patterns from anonymized WPA peptide calculator sessions.
KLOW Blend is a four-peptide healing stack that combines KPV, GHK-Cu, TB-500, and BPC-157 into a single pre-mixed reconstitution. This data shows the combined dose amounts, vial sizes, and bacteriostatic water volumes researchers most commonly select when working with this multi-peptide healing protocol.
KLOW Blend is a four-peptide healing stack — KPV, GHK-Cu, TB-500, and BPC-157 (the K-L-O-W naming derives from the four constituent abbreviations) — assembled into a single pre-mixed lyophilized vial in the research-chemical marketplace. Each of the four constituents has its own preclinical and (in two cases) clinical literature, and the rationale for combining them traces to the way they target distinct phases and mechanisms of the tissue-repair cascade: BPC-157 from the Sikiric et al. program at the University of Zagreb covers angiogenesis and granulation-tissue support; TB-500 (a thymosin beta-4 fragment from the Goldstein et al.
KLOW is a four-peptide research blend of KPV, GHK-Cu, TB-500, and BPC-157, most often sourced for gut-barrier and soft-tissue repair protocols. It ships as a co-lyophilized powder reconstituted with bacteriostatic water before use.
Each component engages a different repair pathway: KPV exerts anti-inflammatory effects via melanocortin-receptor-independent suppression of NF-κB, GHK-Cu delivers bioavailable copper and modulates fibroblast collagen synthesis, TB-500 sequesters G-actin and promotes angiogenesis, and BPC-157 acts on the VEGF–NO axis. The blend is designed around overlapping but non-redundant mechanisms.
No published trials evaluate the four-component blend; evidence is drawn from the individual components. KPV has been studied in IBD models for colitis suppression, GHK-Cu in dermal repair, and BPC-157 / TB-500 in tendon and gut healing models. KLOW has emerged as a popular research-grade combination among researchers studying gut barrier integrity.
KLOW Blend has a reported half-life of ~2 days (TB-500-driven), and the dose intervals researchers model most often fall around once daily. KLOW is a four-peptide blend. TB-500 builds up over the first 1–2 weeks; BPC-157, KPV, and GHK-Cu clear within hours and act per-dose rather than accumulating. It is catalogued under Recovery Peptides on WPA.
5,985 KLOW Blend reconstitution calculations have been logged by the WPA community. The most common dose entered is 2mg (1,315 calculations). The most common bacteriostatic water volume is 3mL. The most popular vial size is 80mg (5,712 sessions). The most common dosing frequency is daily (7x/week) (571 logged protocols), followed by 5x/week (249).
These figures come from anonymized WPA peptide calculator sessions.
All figures shown are aggregated from anonymized calculator inputs and are provided strictly for independent laboratory research and educational purposes. They are community usage statistics — not dosing recommendations, and not medical advice.